3-methoxy-4'-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g

3-(3-Fluorophenyl)-1H-pyrazole-4-carbaldehyde, 97.0%, 1g

tert-Butyl 2-methyl-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate, 97%, 1g

4,5,6,7-Tetrahydropyrazolo[1,5-a]pyridine-2-carboxylic acid, 95.0%, 250mg

4,4,5,5-Tetramethyl-2-(spiro[4.5]Dec-7-en-8-yl)-1,3,2-dioxaborolane, 98%, 500mg

1,12-Dodecanediol Dimethacrylate (stabilized with MEHQ)>93.0%(GC)25g

1-(3-Bromo-6-(trifluoromethyl)pyridin-2-yl)ethanone, 98%, 100mg

6-Isopropyl-benzothiazol-2-ylamine, 95.0%, 250mg

Colonne capillaire GC ROTI®Cap-FFAP, 60 m, 0,25 mm, 0,25 µm, 1 pièce(s)

3-(3,5-Di-tert-butyl-4-hydroxyphenyl)propionic Acid>98.0%(GC)(T)25g

Tris(4-fluorophenyl)boroxine, 98.0%, 10g

3,4-Dimethoxy-2-methylbenzoic acid, 95.0%, 250mg

3-Bromo-4-chloro-5-fluorobenzoic acid, 97%, 250mg